Search Results

Lung Cancer Biomarker Database (LCBD): a comprehensive and curated repository of lung cancer biomarkers.

• Authors : Li Y; Chongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications, Chongqing, 400065, P. R. China. .; Tong Z

Subjects: Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/diagnosis ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/metabolism

• Source: BMC cancer [BMC Cancer] 2025 Mar 15; Vol. 25 (1), pp. 478. Date of Electronic Publication: 2025 Mar 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Diagnostic performance of GLIM and PG-SGA for malnutrition assessment in adult cancer patients: a systematic review and meta-analysis.

• Authors : Zhou, Jielin¹ (AUTHOR); Yang, Shoumei¹ (AUTHOR); Liu, Ting² (AUTHOR)

• Source: BMC Cancer. 4/23/2025, Vol. 25 Issue 1, p1-15. 15p.

Record details

Clinical benefits of deep inspiration breath-hold in postoperative radiotherapy for right-sided breast cancer: a meta-analysis.

• Authors : Li, Zhuocheng¹ (AUTHOR); Jian, Chenxi¹ (AUTHOR); Li, Yuanyuan² (AUTHOR)

• Source: BMC Cancer. 10/8/2024, Vol. 24 Issue 1, p1-8. 8p.

Record details

Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database.

• Authors : Qian, Jiancheng¹ (AUTHOR); Zhang, Shuohan² (AUTHOR); Jiang, Cheng^1,2 (AUTHOR)

• Source: BMC Cancer. 12/3/2024, Vol. 24 Issue 1, p1-13. 13p.

Record details

A comprehensive analysis of different types of databases reveals that CDH1 mRNA and E-cadherin protein are not downregulated in most carcinoma tissues and carcinoma cell lines

• Authors : Brihget Sicairos; Shorna Alam; Yuchun Du

Subjects: CDH1; E-cadherin; Tumor suppressor

• Source: BMC Cancer, Vol 23, Iss 1, Pp 1-18 (2023)

Record details

How frail is frail in oncology studies? A scoping review.

• Authors : Fletcher, James A.^1,2,3 (AUTHOR) ; Logan, Benignus³ (AUTHOR); Reid, Natasha³ (AUTHOR)

• Source: BMC Cancer. 6/2/2023, Vol. 23 Issue 1, p1-16. 16p.

Record details

Incidence and risk of endocrine and metabolic abnormalities linked to PARP inhibitors in solid tumors: a meta-analysis.

• Authors : Fu, Shunlian¹ (AUTHOR); Zou, Pingjin^2,3 (AUTHOR); Fang, Zengyi^2,3 (AUTHOR)

• Source: BMC Cancer. 1/31/2025, Vol. 25 Issue 1, p1-13. 13p.

Record details

Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer

• Authors : Shiyong Gao; Jian Gang; Miao Yu

Subjects: Bioinformatics; Biomarker; Liver cancer

• Source: BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)

Record details

Completeness of regional cancer registry data in Northwest Russia 2008-2017.

• Authors : Barchuk, Anton^1,2,3 (AUTHOR) ; Tursun-zade, Rustam^3,4 (AUTHOR); Nazarova, Ekaterina² (AUTHOR)

• Source: BMC Cancer. 10/18/2023, Vol. 23 Issue 1, p1-11. 11p.

Record details

PD-1 inhibitors improve the efficacy of transcatheter arterial chemoembolization combined with apatinib in advanced hepatocellular carcinoma: a meta-analysis and trial sequential analysis.

• Authors : Yu, Jiahui; Yu, Jinxin; Chen, Yimiao

Subjects: CHEMOEMBOLIZATION; SEQUENTIAL analysis; APATINIB

• Source: BMC Cancer; 3/28/2025, Vol. 25 Issue 1, p1-13, 13p

Record details